| Literature DB >> 26818827 |
Bart Jacobs1, Peter Hill2, Maryam Bigdeli3, Cheanrithy Men4.
Abstract
BACKGROUND: Cambodia developed its public health system along the principles of the district model and geared its services towards managing communicable diseases and maternal and child health issues. In line with other countries in the region, non-communicable diseases have emerged as a leading cause of adult mortality. We assessed the current capacity of the Cambodian district health system to manage hypertension and diabetes, with a focus on access to medicine for these chronic conditions.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26818827 PMCID: PMC4730739 DOI: 10.1186/s12913-016-1286-9
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Study sites’ specifications
| Health District | Population | Social Health Protection Scheme (% population covered by scheme) | Chronic Disease Intervention |
|---|---|---|---|
| Kirivong | 224,401 | VI (3.6), HEF (20.6) | CDC, PEN |
| Samrong | 209,999 | VI (15.9), HEF (28.8) | - |
| Baray-Santuk | 253,260 | HEF (24) | CDC, PEN |
CDC chronic disease clinic, HEF health equity fund, PEN peer education network, VI voluntary insurance
Kind and number of interviewees per category and health district
| Baray-Santuk | Kirivong | Samroang | Total | |
|---|---|---|---|---|
| Provincial Health Department | 1 | 1 | 1 | 3 |
| Operational Health District | 1 | 1 | 1 | 3 |
| Provincial Hospital | 1 | 1 | 1 | 3 |
| District Hospital | 1 | 1 | 1 | 3 |
| Health Centre | 5 | 5 | 5 | 15 |
|
|
|
|
|
|
| Village Health Support Group | 5 | 5 | 5 | 15 |
| Health Centre Management Committee | 5 | 5 | 5 | 15 |
|
|
|
|
|
|
| Peer Education Network | 3 | 3 | 0 | 6 |
| Chronic Disease Clinic | 2 | 1 | 0 | 3 |
| Voluntary Insurance Scheme | 0 | 2 | 2 | 4 |
| Health Equity Funds | 2 | 0 | 2 | 4 |
|
|
|
|
|
|
| Total | 26 | 25 | 23 | 74 |
Indicators of health systems building blocks
|
| access, equity, quality |
|
| domestic budget allocations, out-of-pocket expenditure |
| aid effectiveness, amount of funding | |
|
| planning and coordination, community involvement |
|
| production and strengthening, distribution |
|
| availability and accuracy, use and demand, innovation |
|
| procurement and distribution, quality |
Overview of questions
| Service delivery |
| • Tools and equipment available to diagnose hypertension and diabetes |
| • Ability to manage patients with NCD |
| • Population awareness of NCD services at public facilities |
| • Stage of disease development when patients are diagnosed with NCD |
| • Management of NCD complications |
| • Special services for patients with NCD |
| • Major constraints for adequately managing patients with NCD in public sector |
| Financing |
| • User fee charges per service for NCD |
| • Annual budget per level of health administration and health facility for NCD |
| • Presence of donor-supported programs for NCD |
| • Opinion about effectiveness of social health protection schemes for enabling access to medicine for NCD and financial protection |
| Governance |
| • Presence of national policy or strategy for the treatment and long-term care of NCD |
| • Availability of treatment guidelines for management of NCD |
| • Provision for NCD in planning cycle |
| • Provision of NCD in budgeting |
| • Community involvement in management of NCD |
| • Community initiatives for mobilising resources for patients with NCD |
| • Promotion/education campaigns/activities on NCD |
| Workforce |
| • Presence of staff members who received training in management of NCD |
| • Whether a staff member is in charge for NCD in the facility or administration |
| • Educational background of this person |
| • Additional responsibilities beside NCD |
| • Specific training on NCD |
| • Refresher courses for NCD |
| Health information system |
| • Specific mention of NCD in the health management information system |
| • Presence database system to monitor patients’ adherence with treatment |
| • Availability recall system for dropouts |
| Supply management |
| • Provision of medicines for managing NCD by Central Medical Stores (CMS) |
| • Supply of medicine for NCD in accordance with requirements (needs) |
| • Time period for which a patient receives treatment for NCD at each outpatient consultation |
| • Number of patients to be treated with one quarterly supply by CMS |
| • How long the supply last on average |
| • Where the facility refers patients when NCD drugs are not available |
| • Supply of consumables for diagnosing and monitoring patients with NCD by CMS |
Service provision for NCD patients and perceived challenges to adequately manage them: perspectives from providers and scheme managers
| Providers | Scheme managers | |||
|---|---|---|---|---|
|
|
| |||
| N | % | N | % | |
| What services do you provide for NCD patients? | ||||
| Screening | 22 | 81 | 10 | 59 |
| Diagnostic | 16 | 59 | 9 | 53 |
| Treatment | 18 | 67 | 10 | 59 |
| Follow-up | 16 | 59 | 9 | 53 |
| Management of more complicated cases | 8 | 30 | 2 | 12 |
| Referral of complications | 25 | 93 | 8 | 47 |
| Incentives to stay within the program, | 2 | 7 | 2 | 12 |
| Counselling, lifestyle changes, peer support | 8 | 30 | 9 | 53 |
| Primary prevention of diabetes and hypertension | 0 | 0 | 1 | 6 |
| What are the challenges to adequately manage NCD patients? | ||||
| Medicine availability | 18 | 67 | 15 | 88 |
| Diagnostic tests/screening | 10 | 37 | 7 | 41 |
| Follow-up | 9 | 33 | 6 | 35 |
| Management of more complicated cases | 7 | 26 | 2 | 12 |
| Referral of complications | 4 | 15 | 5 | 29 |
| Incentives to stay within the program | 1 | 4 | 2 | 12 |
| Counselling, lifestyle changes, peer support | 6 | 22 | 6 | 35 |
| Population awareness | 8 | 30 | 5 | 29 |
| Late diagnosis (advances stage) | 4 | 15 | 2 | 12 |
| Establishment of permanent health facility for patients with CNCD | 0 | 0 | 1 | 6 |
| Need specialized medical staff to treat patients with diabetes | 7 | 26 | 3 | 18 |
| Sufficient medical devices | 4 | 15 | 3 | 18 |
Fees charged by public health facilities and NCD interventions (in Khmer riels)
| Type of Health Facility | Na | Mean | SD | Median | Minimum | Maximum |
|---|---|---|---|---|---|---|
| Consultation Fees | ||||||
| Provincial Hospital | 3 | 29,500 | 43,769 | 6000 | 2500 | 80,000 |
| District hospital | 3 | 17,500 | 28,340 | 3750 | 2500 | 60,000 |
| Health center | 13 | 1885 | 893 | 2000 | 500 | 3000 |
| Peer education network | 2 | 4375 | 1750 | 3500 | 3500 | 7000 |
| Chronic Disease Clinicb | 2 | 2667 | 289 | 2500 | 2500 | 3000 |
| Diagnostic Fee | ||||||
| Provincial Hospital | 2 | 6250 | 5303 | 6250 | 2500 | 10,000 |
| District hospital | 1 | 10,000 | 0 | 10,000 | 10,000 | 10,000 |
| Peer education network | 2 | 2720 | 2418 | 2000 | 1300 | 7000 |
| Medicine fee | ||||||
| Provincial Hospital | 1 | 2500 | 0 | 2500 | 2500 | 2500 |
| District hospitals | 0 | 0 | 0 | 0 | 0 | 0 |
| Health center | 1 | 2000 | 0 | 2000 | 2000 | 2000 |
| Peer education network | 2 | 8860 | 5104 | 10,000 | 1300 | 15,000 |
| Laboratory tests | ||||||
| Provincial Hospital | 2 | 3250 | 1061 | 3250 | 2500 | 4000 |
| District hospital | 2 | 6500 | 2121 | 6500 | 5000 | 8000 |
| Health center | 1 | 1500 | 0 | 1500 | 1500 | 1500 |
| Peer education network | 2 | 22,100 | 224 | 22,000 | 22,000 | 22,500 |
adenotes the number of facilities/schemes charging fees. For peer education networks and chronic disease clinics averages are given based on the sum of figures provided by the respective respondents; bconsultation fee covers medicines and laboratory tests
Reported amount of medicines supplied to patients and estimated number of patient who can be managed per quarterly supply by Central Medical Stores
| Mean (SD) | Median (Min-Max) | |
|---|---|---|
| Amount of medicine supplied to patients for each visit (in days) | ||
| Provincial hospital | 19 (12) | 20 (7–30) |
| District hospital | 9 (6) | 7 (4–15) |
| Health centre | 4 (1) | 3 (3–5) |
| Peer education | 28 (6) | 30 (15–30) |
| Chronic disease clinic | 27 (6) | 30 (20–30) |
| Number of patients who can be treated with each supply by CMS: diabetes | ||
| Provincial hospital | 5 (0) | 5 (5–5) |
| District hospital | 6 (1) | 7 (5–7) |
| Peer education | 859 (1757) | 80 (5–4000) |
| Chronic disease clinic | 578 (85) | 600 (485–650) |
| Number of patients who can be treated with each supply by CMS: Hypertension | ||
| Provincial hospital | 6 (0) | 6 (6–6) |
| District hospital | 118 (182) | 16 (11–328) |
| Health centre | 16 (22) | 10 (3–90) |
| Peer education | 569 (1080) | 100 (7–2500) |
| Chronic disease clinic | 309 (117) | 350 (177–400) |
CMS central medical stores, SD standard deviation
Reported and observed available essential medicine for hypertension and diabetes
| Medicine | Health centre | District hospital | PH | CDC | PEN | ||
|---|---|---|---|---|---|---|---|
| Interviewa | Assessedb | Interview | Assessed | ||||
| N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
|
| |||||||
| Hydrochlorothiazide | 5 (33) | 12 (86) | 3 (100) | 1 (33) | 0 | 1 (50) | 2 (100) |
| Amlodipine | 1 (7) | 1 (7) | 2 (67) | 2 (67) | 1 (33) | 2 (100) | 2 (100) |
| Atenolol | 1 (7) | 2 (14) | 3 (100) | 3 (100) | 2 (67) | 2 (100) | 2 (100) |
| Captopril | NEDL | 0 | 2 (67) | 1 (33) | 1 (50) | 2 (100) | |
| Enalapril | NEDL | 1 (33) | 3 (100) | 1 (33) | 2 (100) | 2 (100) | |
| Losartan | NEDL | 0 | 0 | 0 | 0 | 1 (50) | |
| Nifedipine | NEDL | 1 (33) | 2 (67) | 0 | 0 | 0 | |
|
| |||||||
| Metformine | NEDL | 1 (33) | 2 (67) | 2 (67) | 2 (100) | 2 (100) | |
| Glibenclamide | NEDL | 1 (33) | 2 (67) | 1 (33) | 1 (50) | 2 (100) | |
| Insuline NPH | NEDL | 0 | 1 (33) | 1 (33) | 2 (100) | 2 (100) | |
CDC chronic disease clinic, PEN peer education network, PH provincial hospital, NEDL not on essential drug list; a15 facilities; b14 facilities